Company intelligence / Profile preview

Interlabo

Ownership: Private
Development stage: Other

Overview

Interlab designs and manufactures fully automatic protein electrophoresis systems and reagents. Over 4,000 units have been sold worldwide. The company emphasizes high automation, analytical speed, quality results, and robust technical support. It reinvests heavily in R&D to maintain innovation leadership in its field.

Modalities: DeviceReagent (for protein electrophoresis; not therapeutics)
Industry: Protein Biomarker Diagnostics

Partnerships

Global distributor network trained at Interlab facilities; no major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on Interlabo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interlabo.

Explore the full profile